<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Antipsychotic,Antipsychotics,Major Drug Groups,Antipsychotics,Major Drug Groups,ACE inhibitor,ATC code N05,Adverse effect (medicine),Agranulocytosis,Akathisia,Allergy" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Antipsychotic - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Antipsychotic</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <p>The term <b>antipsychotic</b> is applied to a group of <a href="../../../m/e/d/Medication.html" title="Medication">drugs</a> used to treat <a href="../../../p/s/y/Psychosis.html" title="Psychosis">psychosis</a>. Common conditions with which antipsychotics might be used include <a href="../../../s/c/h/Schizophrenia.html" title="Schizophrenia">schizophrenia</a>, <a href="../../../m/a/n/Mania.html" title="Mania">mania</a> and <a href="../../../d/e/l/Delusional_disorder.html" title="Delusional disorder">delusional disorder</a>, although antipsychotics might be used to counter psychosis associated with a wide range of other diagnoses. Antipsychotics also have some effects as <a href="../../../m/o/o/Mood_stabilizer.html" title="Mood stabilizer">mood stabilizers</a>, leading to their frequent use in treating <a href="../../../m/o/o/Mood_disorder.html" title="Mood disorder">mood disorder</a> (particularly <a href="../../../b/i/p/Bipolar_disorder.html" title="Bipolar disorder">bipolar disorder</a>) even when no signs of psychosis are present. Some antipsychotics (<a href="../../../h/a/l/Haloperidol.html" title="Haloperidol">haloperidol</a>, <a href="../../../p/i/m/Pimozide.html" title="Pimozide">pimozide</a>) are used <a href="../../../o/f/f/Off-label_use.html" title="Off-label use">off-label</a> to treat <a href="../../../t/o/u/Tourette_syndrome.html" title="Tourette syndrome">Tourette syndrome</a>.</p>
<p>Antipsychotics are also referred to as <b>neuroleptic drugs</b>, or simply <b>neuroleptics</b>. The word <i>neuroleptic</i> is derived from <a href="../../../g/r/e/Greek_language.html" title="Greek language">Greek</a>; <i>neuro</i> refers to the <a href="../../../n/e/r/Nerve.html" title="Nerve">nerves</a> and <i>lept</i> means "to take hold of". Thus the word means "taking hold of one's nerves", which implies their role in mood stabilization.</p>
<p>There are currently two main types of antipsychotics in use, the <a href="../../../t/y/p/Typical_antipsychotic.html" title="Typical antipsychotic">typical antipsychotics</a> and <a href="../../../a/t/y/Atypical_antipsychotic.html" title="Atypical antipsychotic">atypical antipsychotics</a>. A new class of antipsychotic drugs has recently been discovered, known as dopamine partial agonists. Clinical development has progressed rapidly on partial dopamine agonists, and one drug in this class (<a href="../../../a/r/i/Aripiprazole.html" title="Aripiprazole">aripiprazole</a>) has already been approved by the <a href="../../../f/o/o/Food_and_Drug_Administration_b75c.html" title="Food and Drug Administration">Food and Drug Administration</a>. Although the underlying mechanism of this new class is different from all previous typical and atypical antipsychotics, dopamine partial agonists are often categorized as atypicals.</p>
<p>Typical antipsychotics are sometimes referred to as <b>major tranquilizers</b>, because some of them can tranquilize and sedate. This term is increasingly disused because many newer antipsychotics do not have strong sedating properties and the terminology implies a connection with <a href="../../../b/e/n/Benzodiazepine.html" title="Benzodiazepine">benzodiazepines</a> when none exists.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Common_antipsychotic_drugs"><span class="tocnumber">1</span> <span class="toctext">Common antipsychotic drugs</span></a></li>
<li class="toclevel-1"><a href="#Drug_action_and_effectiveness"><span class="tocnumber">2</span> <span class="toctext">Drug action and effectiveness</span></a></li>
<li class="toclevel-1"><a href="#Side_effects"><span class="tocnumber">3</span> <span class="toctext">Side effects</span></a></li>
<li class="toclevel-1"><a href="#Criticism"><span class="tocnumber">4</span> <span class="toctext">Criticism</span></a></li>
<li class="toclevel-1"><a href="#Typical_vs_Atypical_comparison"><span class="tocnumber">5</span> <span class="toctext">Typical vs Atypical comparison</span></a></li>
<li class="toclevel-1"><a href="#History_and_design"><span class="tocnumber">6</span> <span class="toctext">History and design</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">7</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Common_antipsychotic_drugs" id="Common_antipsychotic_drugs"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antipsychotic.html" title="Edit section: Common antipsychotic drugs">edit</a>]</span> <span class="mw-headline">Common antipsychotic drugs</span></h2>
<p>Commonly used antipsychotic medications are listed below by drug group. Trade names appear in parentheses.</p>
<ul>
<li><a href="../../../t/y/p/Typical_antipsychotic.html" title="Typical antipsychotic">Typical antipsychotics</a>:
<ul>
<li><a href="../../../p/h/e/Phenothiazines.html" title="Phenothiazines">Phenothiazines</a>:
<ul>
<li><a href="../../../c/h/l/Chlorpromazine.html" title="Chlorpromazine">Chlorpromazine</a> (Thorazine®)</li>
<li><a href="../../../f/l/u/Fluphenazine.html" title="Fluphenazine">Fluphenazine</a> (Prolixin®) - Available in decanoate (long acting) form</li>
<li><a href="../../../p/e/r/Perphenazine.html" title="Perphenazine">Perphenazine</a> (Trilafon®)</li>
<li><a href="../../../p/r/o/Prochlorperazine.html" title="Prochlorperazine">Prochlorperazine</a> (Compazine®)</li>
<li><a href="../../../t/h/i/Thioridazine.html" title="Thioridazine">Thioridazine</a> (Mellaril®)</li>
<li><a href="../../../t/r/i/Trifluoperazine.html" title="Trifluoperazine">Trifluoperazine</a> (Stelazine®)</li>
</ul>
</li>
<li><a href="../../../b/u/t/Butyrophenones.html" title="Butyrophenones">Butyrophenones</a>
<ul>
<li><a href="../../../h/a/l/Haloperidol.html" title="Haloperidol">Haloperidol</a> (Haldol®) - Available in decanoate (long acting) form</li>
<li><a href="../../../d/r/o/Droperidol.html" title="Droperidol">Droperidol</a></li>
<li><a href="../../../p/i/m/Pimozide.html" title="Pimozide">Pimozide</a> (Orap®) - Used to treat <a href="../../../t/o/u/Tourette_syndrome.html" title="Tourette syndrome">Tourette syndrome</a></li>
</ul>
</li>
</ul>
</li>
</ul>
<ul>
<li><a href="../../../a/t/y/Atypical_antipsychotic.html" title="Atypical antipsychotic">Atypical antipsychotics</a>:
<ul>
<li><a href="../../../c/l/o/Clozapine.html" title="Clozapine">Clozapine</a> (Clozaril®) - Requires weekly to biweekly <a href="../../../c/o/m/Complete_blood_count.html" title="Complete blood count">CBC (FBC)</a> because of risk of <a href="../../../a/g/r/Agranulocytosis.html" title="Agranulocytosis">agranulocytosis</a> (a severe decrease of <a href="../../../w/h/i/White_blood_cells.html" title="White blood cells">white blood cells</a>).</li>
<li><a href="../../../o/l/a/Olanzapine.html" title="Olanzapine">Olanzapine</a> (Zyprexa®) - Used to treat psychotic disorders including acute manic episodes and maintenance of bipolar disorder. Dosing 2.5 mg to 20 mg per day. Comes in a form that quickly dissolves in the mouth (Zyprexa Zydis). May cause appetite increase, weight gain and altered glucose metabolism leading to an increased risk of diabetes mellitus.</li>
<li><a href="../../../r/i/s/Risperidone.html" title="Risperidone">Risperidone</a> (Risperdal®) - Dosing 0.25 to 6 mg per day and is titrated upward; divided dosing is recommended until initial titration is completed at which time the drug can be administered once daily. Available in long-acting form (Risperdal Consta that is administered every 2 weeks; usual dose is 25 mg). Comes in a form that quickly dissovles in the mouth (Risperdal M-Tab). Used off-label to treat <a href="../../../t/o/u/Tourette_Syndrome_1d1b.html" title="Tourette Syndrome">Tourette Syndrome</a>.</li>
<li><a href="../../../q/u/e/Quetiapine.html" title="Quetiapine">Quetiapine</a> (Seroquel®) - Used primarily to treat bipolar disorder and schizophrenia, and "off label" to treat chronic <a href="../../../i/n/s/Insomnia.html" title="Insomnia">insomnia</a> and <a href="../../../r/e/s/Restless_legs_syndrome.html" title="Restless legs syndrome">restless legs syndrome</a>; it is a powerful sedative (if it's used to treat sleep disorders and is not effective at 200 mg, it is not going to be effective in this regard). Dosing starts at 25 mg and continues up to 800 mg maximum per day, depending on the severity of the symptom(s) being treated. Users typically take smaller doses during the day for the neuroleptic properties and larger dose at bedtime for the sedative effects, or divided in two equally high doses every 12 hours (75-400mg bid).</li>
<li><a href="../../../z/i/p/Ziprasidone.html" title="Ziprasidone">Ziprasidone</a> (Geodon®) - Now (2006) approved to treat bipolar disorder. Dosing 20 mg twice daily initially up to 80 mg twice daily. Prolonged <a href="../../../q/t/_/QT_interval_4e62.html" title="QT interval">QT interval</a> a concern; watch closely with patients who have heart disease; when used with other drugs that prolong QT interval potentially life-threatening.</li>
<li><a href="../../../a/m/i/Amisulpride.html" title="Amisulpride">Amisulpride</a> (Solian®) - Selective dopamine antagonist. Higher doses (greater than 400 mg) act upon post-synaptic dopamine receptors resulting in a reduction in the positive symptoms of schizophrenia, such as psychosis. Lower doses however act upon dopamine autoreceptors, resulting in increased dopamine transmission, improving the negative symptoms of schizophrenia. Lower doses of amisulpride have also been shown to have <a href="../../../a/n/t/Anti-depressant.html" title="Anti-depressant">anti-depressant</a> and <a href="../../../a/n/x/Anxiolytic.html" title="Anxiolytic">anxiolytic</a> effects in non-schizophrenic patients, leading to its use in <a href="../../../d/y/s/Dysthymia.html" title="Dysthymia">dysthymia</a> and <a href="../../../s/o/c/Social_anxiety_disorder.html" title="Social anxiety disorder">social anxiety disorder</a>. In one particular study, amisulpride was found to have greater efficacy than <a href="../../../f/l/u/Fluoxetine.html" title="Fluoxetine">fluoxetine</a> in decreasing anxiety. Currently, amisulpride is approved in Europe, Australia and other countries for use in schizophrenia, and is approved and marketed in lower dosages in some countries for treating dysthymia (such as in Italy as Deniban®). Amisulpride has not been approved by the FDA for use in the United States.</li>
<li><a href="../../../m/e/l/Melperone.html" title="Melperone">Melperone</a></li>
<li><a href="../../../p/a/l/Paliperidone.html" title="Paliperidone">Paliperidone</a> (Invega®) - Derivative of risperidone. Approved in December 2006.</li>
</ul>
</li>
</ul>
<ul>
<li>Dopamine <a href="../../../p/a/r/Partial_agonist.html" title="Partial agonist">partial agonists</a>:
<ul>
<li><a href="../../../a/r/i/Aripiprazole.html" title="Aripiprazole">Aripiprazole</a> (Abilify®) - Dosing 5 mg up to maximum of 30 mg has been used. Mechanism of action is thought to reduce susceptibility to metabolic symptoms seen in some other atypical antipsychotics.</li>
<li>Under clinical development - Bifeprunox; norclozapine (ACP-104).</li>
</ul>
</li>
</ul>
<ul>
<li>Other options
<ul>
<li><a href="../../../s/y/m/Symbyax.html" title="Symbyax">Symbyax</a> - A combination of <a href="../../../o/l/a/Olanzapine.html" title="Olanzapine">olanzapine</a> and <a href="../../../f/l/u/Fluoxetine.html" title="Fluoxetine">fluoxetine</a> used in the treatment of bipolar depression.</li>
<li><a href="../../../t/e/t/Tetrabenazine.html" title="Tetrabenazine">Tetrabenazine</a> (Nitoman® in Canada and Xenazine® in New Zealand and some parts of Europe) is similar in function to antipsychotic drugs, though isn't generally considered an antipsychotic itself. This is likely due to its main usefulness being the treatment of hyperkinetic <a href="../../../m/o/v/Movement_disorder.html" title="Movement disorder">movement disorders</a> such as <a href="../../../h/u/n/Huntington%27s_Disease_6be9.html" title="Huntington's Disease">Huntington's Disease</a> and <a href="../../../t/o/u/Tourette_syndrome.html" title="Tourette syndrome">Tourette syndrome</a>, rather than for conditions such as <a href="../../../s/c/h/Schizophrenia.html" title="Schizophrenia">schizophrenia</a>. Also, rather than having the potential to cause <a href="../../../t/a/r/Tardive_dyskinesia.html" title="Tardive dyskinesia">tardive dyskinesia</a> that most antipsychotics have, tetrabenazine can actually be an effective <i>treatment</i> for the condition.</li>
</ul>
</li>
</ul>
<p>The most common typical antipsychotic drugs are now <a href="../../../p/a/t/Patent.html" title="Patent">off-patent</a>, meaning any pharmaceutical company is legally allowed to produce cheap <a href="../../../g/e/n/Generic_drug.html" title="Generic drug">generic</a> versions of these medications. While this makes them cheaper than the atypical drugs which are still manufactured under patent constraints, atypical drugs are preferred as a first line treatment because they are believed to have fewer side effects and seem to have additional benefits for the 'negative symptoms' of <a href="../../../s/c/h/Schizophrenia.html" title="Schizophrenia">schizophrenia</a>, a typical condition for which they might be prescribed.</p>
<p><a name="Drug_action_and_effectiveness" id="Drug_action_and_effectiveness"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antipsychotic.html" title="Edit section: Drug action and effectiveness">edit</a>]</span> <span class="mw-headline">Drug action and effectiveness</span></h2>
<p>All antipsychotic drugs tend to block the <a href="../../../d/o/p/Dopamine_receptor.html" title="Dopamine receptor">D<sub>2</sub> receptors</a> in the <a href="../../../d/o/p/Dopamine.html" title="Dopamine">dopamine</a> pathways in the <a href="../../../b/r/a/Brain.html" title="Brain">brain</a>, so the normal effect of dopamine release in the relevant <a href="../../../s/y/n/Synapse.html" title="Synapse">synapses</a> is reduced.</p>
<p>It is the blockade of D<sub>2</sub> receptors in the <a href="../../../m/e/s/Mesolimbic_pathway.html" title="Mesolimbic pathway">mesolimbic pathway</a> of the <a href="../../../b/r/a/Brain.html" title="Brain">brain</a> which is thought to produce the intended antipsychotic effect.</p>
<p>Typical antipsychotics are not particularly selective and also block the same receptors in the <a href="../../../m/e/s/Mesocortical_pathway.html" title="Mesocortical pathway">mesocortical pathway</a>, <a href="../../../t/u/b/Tuberoinfundibular_pathway.html" title="Tuberoinfundibular pathway">tuberoinfundibular pathway</a> and the <a href="../../../n/i/g/Nigrostriatal_pathway.html" title="Nigrostriatal pathway">nigrostriatal pathway</a>. Blocking D<sub>2</sub> receptors in these other pathways is thought to produce some of the unwanted <a href="../../../a/d/v/Adverse_effect_%28medicine%29.html" title="Adverse effect (medicine)">side effects</a> that the typical antipsychotics can produce (see below).</p>
<p>Atypical antipsychotic drugs have a similar blocking effect on D<sub>2</sub> receptors but seem to be a little more selective, targeting the intended pathway to a larger degree than the others. They also block or partially block <a href="../../../s/e/r/Serotonin.html" title="Serotonin">serotonin</a> receptors (particularly 5HT<sub>2A, C</sub> and 5HT<sub>1A</sub> receptors).</p>
<p>This combination of effects on both dopamine and serotonin receptors might be why atypical antipsychotic drugs tend to have fewer side effects than typicals and have a seemingly additional effect on the 'negative symptoms' of schizophrenia.</p>
<p>Anti-psychotics can be classified on a spectrum of low potency to high potency, where potency refers to the ability of the drug to bind to dopamine receptors, and not to the effectiveness of the drug. High potency antipsychotics such as <a href="../../../h/a/l/Haloperidol.html" title="Haloperidol">haloperidol</a> typically have doses of a few milligrams and cause less sleepiness and calming effects than low potency antipsychotics such as <a href="../../../c/h/l/Chlorpromazine.html" title="Chlorpromazine">chlorpromazine</a>, which have dosages of several hundred milligrams.</p>
<p>Some people who become psychotic do not seem to respond to antipsychotic medication, despite studies showing that the drug is blocking the same number of receptors as in other people who do respond to the treatment.</p>
<p><a name="Side_effects" id="Side_effects"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antipsychotic.html" title="Edit section: Side effects">edit</a>]</span> <span class="mw-headline">Side effects</span></h2>
<p>The range of interactions can produce different adverse effects including <a href="../../../e/x/t/Extrapyramidal_side-effect.html" title="Extrapyramidal side-effect">extrapyramidal</a> reactions, including acute <a href="../../../d/y/s/Dystonia.html" title="Dystonia">dystonias</a>, <a href="../../../a/k/a/Akathisia.html" title="Akathisia">akathisia</a>, <a href="../../../p/a/r/Parkinsonism.html" title="Parkinsonism">parkinsonism</a> (rigidity and <a href="../../../t/r/e/Tremor.html" title="Tremor">tremor</a>), <a href="../../../t/a/r/Tardive_dyskinesia.html" title="Tardive dyskinesia">tardive dyskinesia</a>, <a href="../../../t/a/c/Tachycardia.html" title="Tachycardia">tachycardia</a>, <a href="../../../h/y/p/Hypotension.html" title="Hypotension">hypotension</a>, <a href="../../../i/m/p/Impotence.html" title="Impotence">impotence</a>, lethargy, <a href="../../../s/e/i/Seizure.html" title="Seizure">seizures</a>, and <a href="../../../h/y/p/Hyperprolactinaemia.html" title="Hyperprolactinaemia">hyperprolactinaemia</a>.</p>
<p>The atypical antipsychotics (especially <a href="../../../o/l/a/Olanzapine.html" title="Olanzapine">olanzapine</a>) seem to cause weight gain more commonly than the typical antipsychotics. The well documented metabolic side effects associated with weight gain include diabetes that, not infrequently, can be life threatening.</p>
<p><a href="../../../c/l/o/Clozapine.html" title="Clozapine">Clozapine</a> also has a risk of inducing <a href="../../../a/g/r/Agranulocytosis.html" title="Agranulocytosis">agranulocytosis</a>, a potentially dangerous reduction in the number of white blood cells in the body. Because of this risk, patients prescribed clozapine may need to have regular blood checks to catch the condition early if it does occur, so the patient is in no danger.</p>
<p>One of the more serious of these side effects is <a href="../../../t/a/r/Tardive_dyskinesia.html" title="Tardive dyskinesia">tardive dyskinesia</a>, in which the sufferer may show repetitive, involuntary, purposeless movements often of the lips, face, legs or torso. (Photos and video can be seen <a href="http://www.yoism.org/?q=node/120" class="external text" title="http://www.yoism.org/?q=node/120" rel="nofollow">here</a>). It is believed that there is a greater risk of developing tardive dyskinesia with the older, typical antipsychotic drugs, although the newer antipsychotics are now also known to cause this disorder. It is believed by some that the risk of tardive dyskinesia can be reduced by combining the anti-psychotics with <a href="../../../d/i/p/Diphenhydramine.html" title="Diphenhydramine">diphenhydramine</a> or <a href="../../../b/e/n/Benztropine.html" title="Benztropine">benztropine</a>, though this has not been established. <a href="../../../c/e/n/Central_nervous_system.html" title="Central nervous system">Central nervous system</a> damage is also associated with irreversible tardive <a href="../../../a/k/a/Akathisia.html" title="Akathisia">akathisia</a> and/or <a href="../../../t/a/r/Tardive_dysphrenia.html" title="Tardive dysphrenia">tardive dysphrenia</a>.</p>
<p>A potentially serious side effect of many antipsychotics is that they tend to lower an individuals seizure threshold. Chlorpromazine and clozapine particularly, have a relatively high seizurogenic potential. Fluphenazine, haloperidol, pimozide and risperidone exhibit a relatively low risk. Caution should be exercised in individuals that have a history of seizurogenic conditions (such as <a href="../../../e/p/i/Epilepsy.html" title="Epilepsy">epilepsy</a>, or <a href="../../../b/r/a/Brain_damage.html" title="Brain damage">brain damage</a>).</p>
<p>Another serious side effect is <a href="../../../n/e/u/Neuroleptic_malignant_syndrome.html" title="Neuroleptic malignant syndrome">neuroleptic malignant syndrome</a>, in which the drugs appear to cause the temperature regulation centers to fail, resulting in a medical emergency as the patient's temperature suddenly increases to dangerous levels.</p>
<p>Another problematic side effect of antipsychotics is <a href="../../../d/y/s/Dysphoria.html" title="Dysphoria">dysphoria</a>, meaning that it just makes the patient feel bad. This side-effect is a major problem for patients with schizophrenia in that it causes them to discontinue medication, and this produces a relapse of psychotic symptoms.<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since February 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></p>
<p>Whilst this may seem a daunting list, it must be noted that some people suffer few of the obvious side effects from taking antipsychotic medication. Some side effects, such as subtle cognitive problems, may go unnoticed.</p>
<p>Other symptoms of akinesia of antipsychotics include deterioration of teeth due to a lack of saliva. The link between such symptoms and the use of antipsychotics is often overlooked.</p>
<p><a name="Criticism" id="Criticism"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antipsychotic.html" title="Edit section: Criticism">edit</a>]</span> <span class="mw-headline">Criticism</span></h2>
<p>Several studies have been published showing that the use of neuroleptics actually leads to poorer outcomes than no treatment at all.<sup class="noprint">[<i><a href="../../../s/y/n/WP%7ESYN_b7b5.html" title="WP:SYN"><span title="The material in the vicinity of this tag may be based upon improper synthesis." style="white-space: nowrap;">improper synthesis?</span></a></i>]</sup> The World Health Organization published a study showing that countries in the developing world have outcomes that are twice as good as developed nations for people diagnosed with schizophrenia.<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[1]</a></sup> A dose response effect has also been found in one study from 1971 between increasing neuroleptic dose and increasing number of psychotic breaks.<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[2]</a></sup><sup class="noprint">[<a href="../../../a/t/t/Wikipedia%7EAttribution_916a.html" title="Wikipedia:Attribution"><i><span title="The material in the vicinity of this tag needs to be fact-checked with the cited source(s)." style="white-space: nowrap;">verification needed</span></i></a>]</sup> It is theorized that after neuroleptics block dopamine receptors, the brain responds by growing more and more sensitive receptors. If the patient abruptly withdraws after this has happened, he or she experiences a flood of dopamine and has a break.<sup id="_ref-2" class="reference"><a href="#_note-2" title="">[3]</a></sup><sup class="noprint">[<i><a href="../../../d/i/s/Wikipedia%7EDisputed_statement_0636.html" title="Wikipedia:Disputed statement"><span title="The material in the vicinity of this tag may not be factual or accurate." style="white-space: nowrap;">dubious</span></a> <font class="metadata">— see <a href="../../../a/n/t/Talk%7EAntipsychotic_3bb2.html#Disputed" title="Talk:Antipsychotic">talk page</a></font></i>]</sup> The use of antipsychotic drugs is also possibly the most frequent target of criticism by <a href="../../../a/n/t/Anti-psychiatry.html" title="Anti-psychiatry">anti-psychiatry</a> groups, particularly the <a href="../../../c/h/u/Church_of_Scientology_879d.html" title="Church of Scientology">Church of Scientology</a>.<sup class="noprint Template-Fact"><a href="../../../c/i/t/Wikipedia%7ECiting_sources_8ba4.html" title="Wikipedia:Citing sources"><span title="This claim needs references to reliable sources since April 2007" style="white-space: nowrap;">[<i>citation needed</i>]</span></a></sup></p>
<p><a name="Typical_vs_Atypical_comparison" id="Typical_vs_Atypical_comparison"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antipsychotic.html" title="Edit section: Typical vs Atypical comparison">edit</a>]</span> <span class="mw-headline">Typical vs Atypical comparison</span></h2>
<p>While the atypical, second-generation medications were marketed as offering greater efficacy in reducing psychotic symptoms while reducting side effects (and extra-pyramidal symptoms in particular) than typical medications, these results showing these effects often lack robustness. To remediate this problem, the <a href="../../../n/i/m/NIMH_977b.html" title="NIMH">NIMH</a> conducted a recent multi-site, double-blind, study (the CATIE project), which was published in 2005.<sup id="_ref-3" class="reference"><a href="#_note-3" title="">[4]</a></sup> This study compared several atypical antipsychotics to an older typical antipsychotic, <a href="../../../p/e/r/Perphenazine.html" title="Perphenazine">perphenazine</a>, among 1493 persons with schizophrenia. Perphenazine was chosen because of its lower potency and moderate side-effect profile. The study found that only <a href="../../../o/l/a/Olanzapine.html" title="Olanzapine">olanzapine</a> outperformed perphenazine in the researchers' principal outcome, the discontinuation rate. The authors also noted the apparent superior efficacy of olanzapine to the other drugs for greater reduction in psychopathology, longer duration of successful treatment, and lower rate of hospitalizations for an exacerbation of schizophrenia. In contrast, no other atypical studied (<a href="../../../r/i/s/Risperidone.html" title="Risperidone">risperidone</a>, <a href="../../../q/u/e/Quetiapine.html" title="Quetiapine">quetiapine</a>, and <a href="../../../z/i/p/Ziprasidone.html" title="Ziprasidone">ziprasidone</a>) did better than the typical perphenazine on those measures. Olanzapine, however, was associated with relatively severe metabolic effects: subjects with olanzapine showed a major weight gain problem and increases in glucose, cholesterol, and triglycerides. The average weight gain (1.1 kg/month, or 44 pounds for the 18 months that lasted the study) casts serious doubt on the potentiality of long-term use of this drug. Perphenazine did not create more extrapyramidal side-effect as measured by rating scales (a result supported by a meta-analysis by Dr. Leucht published in Lancet), although more patients discontinued perphenazine owing to extrapyramidal effects compared to the atypical agents (8 percent vs. 2 percent to 4 percent, P=0.002).</p>
<p>A phase 2 part of this study roughly replicated these findings.<sup id="_ref-4" class="reference"><a href="#_note-4" title="">[5]</a></sup> This phase consisted on a second randomization of the patients who discontinuated the taking of medication in the first phase. Olanzapine was again the only medication to stand out in the outcome measures, although the results did not always reach statistical significance, in part to the decrease of power. Perphenazine again did not create more extrapyramidal effects.</p>
<p>A subsequent phase was conducted. <sup id="_ref-5" class="reference"><a href="#_note-5" title="">[6]</a></sup> This phase innovated in allowing clinicians to offer <a href="../../../c/l/o/Clozapine.html" title="Clozapine">clozapine</a>. Clozapine indeed proved to be more effective at reducing medication drop-outs than other neuroleptic agents. Researchers also observed a trend showing clozapine with a greater reduction of symptoms. However, the potential of clozapine to cause toxic side effects, including agranulocytosis, limits the prescription to persons with schizophrenia.</p>
<p><a name="History_and_design" id="History_and_design"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antipsychotic.html" title="Edit section: History and design">edit</a>]</span> <span class="mw-headline">History and design</span></h2>
<p>The original antipsychotic drugs were happened upon largely by chance and were tested empirically for their effectiveness.</p>
<p>The first antipsychotic was <a href="../../../c/h/l/Chlorpromazine.html" title="Chlorpromazine">chlorpromazine</a>, which was developed as a surgical <a href="../../../a/n/e/Anesthetic.html" title="Anesthetic">anesthetic</a>. It was first used on psychiatric patients in the belief that it would have a calming effect. However, the drug soon appeared to reduce psychosis beyond this calming effect, and now some believe that it causes a reduction of psychosis unrelated to the sedating effect of the medication. It was introduced for the treatment of psychosis during the period when <a href="../../../l/o/b/Lobotomy.html" title="Lobotomy">lobotomy</a> was a common treatment and was hailed as a "cure" for schizophrenia. It was then touted to provide a "chemical lobotomy," causing similar neurological effects without requiring surgery.</p>
<p>The newer atypical antipsychotics are supposedly <a href="../../../r/a/t/Rational_drug_design.html" title="Rational drug design">rationally designed drugs</a> in which a theoretical understanding of both the condition to be treated and the effect of certain molecules on the body is used to develop potential new drug candidates.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antipsychotic.html" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="../../../d/o/p/Dopamine.html" title="Dopamine">Dopamine</a></li>
<li><a href="../../../d/o/p/Dopamine_hypothesis_of_schizophrenia.html" title="Dopamine hypothesis of schizophrenia">Dopamine hypothesis of schizophrenia</a></li>
<li><a href="../../../p/s/y/Psychosis.html" title="Psychosis">Psychosis</a></li>
<li><a href="../../../s/c/h/Schizophrenia.html" title="Schizophrenia">Schizophrenia</a></li>
<li><a href="../../../t/a/r/Tardive_dysphrenia.html" title="Tardive dysphrenia">Tardive dysphrenia</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antipsychotic.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small">
<ol class="references">
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <cite style="font-style:normal">Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper J, Day R, Bertelsen A. "Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study". <i>Psychol Med Monogr Suppl</i> <b>20</b>: 1-97. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1565705" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1565705">PMID 1565705</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Schizophrenia%3A+manifestations%2C+incidence+and+course+in+different+cultures.+A+World+Health+Organization+ten-country+study&amp;rft.title=Psychol+Med+Monogr+Suppl&amp;rft.jtitle=Psychol+Med+Monogr+Suppl&amp;rft.volume=20&amp;rft.au=Jablensky+A%2C+Sartorius+N%2C+Ernberg+G%2C+Anker+M%2C+Korten+A%2C+Cooper+J%2C+Day+R%2C+Bertelsen+A&amp;rft.pages=1-97&amp;rft_id=info:pmid/1565705">&#160;</span></li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> <cite style="font-style:normal">Prien R, Levine J, Switalski R (1971). "Discontinuation of chemotherapy for chronic schizophrenics". <i>Hosp Community Psychiatry</i> <b>22</b> (1): 4-7. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=4992967" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=4992967">PMID 4992967</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Discontinuation+of+chemotherapy+for+chronic+schizophrenics&amp;rft.title=Hosp+Community+Psychiatry&amp;rft.jtitle=Hosp+Community+Psychiatry&amp;rft.date=1971&amp;rft.volume=22&amp;rft.issue=1&amp;rft.au=Prien+R%2C+Levine+J%2C+Switalski+R&amp;rft.pages=4-7&amp;rft_id=info:pmid/4992967">&#160;</span></li>
<li id="_note-2"><b><a href="#_ref-2" title="">^</a></b> <cite class="book" style="font-style:normal">Whitaker, R.. <i>Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill.</i>. Perseus Publishing.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Mad+in+America%3A+Bad+Science%2C+Bad+Medicine%2C+and+the+Enduring+Mistreatment+of+the+Mentally+Ill.&amp;rft.title=Mad+in+America%3A+Bad+Science%2C+Bad+Medicine%2C+and+the+Enduring+Mistreatment+of+the+Mentally+Ill.&amp;rft.au=Whitaker%2C+R.&amp;rft.pub=Perseus+Publishing">&#160;</span></li>
<li id="_note-3"><b><a href="#_ref-3" title="">^</a></b> <cite style="font-style:normal">Lieberman J et al (2005). "<a href="http://content.nejm.org/cgi/content/abstract/353/12/1209" class="external text" title="http://content.nejm.org/cgi/content/abstract/353/12/1209" rel="nofollow">Effectiveness of antipsychotic drugs in patients with chronic schizophrenia</a>". <i>N Engl J Med</i> <b>353</b> (12): 1209-23. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16172203" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16172203">PMID 16172203</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Effectiveness+of+antipsychotic+drugs+in+patients+with+chronic+schizophrenia&amp;rft.title=N+Engl+J+Med&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2005&amp;rft.volume=353&amp;rft.issue=12&amp;rft.au=Lieberman+J+et+al&amp;rft.pages=1209-23&amp;rft_id=info:pmid/16172203&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Fabstract%2F353%2F12%2F1209">&#160;</span></li>
<li id="_note-4"><b><a href="#_ref-4" title="">^</a></b> <cite style="font-style:normal">Stroup T et al (2006). "Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic". <i>Am J Psychiatry</i> <b>163</b> (4): 611-22. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16585435" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16585435">PMID 16585435</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Effectiveness+of+olanzapine%2C+quetiapine%2C+risperidone%2C+and+ziprasidone+in+patients+with+chronic+schizophrenia+following+discontinuation+of+a+previous+atypical+antipsychotic&amp;rft.title=Am+J+Psychiatry&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.date=2006&amp;rft.volume=163&amp;rft.issue=4&amp;rft.au=Stroup+T+et+al&amp;rft.pages=611-22&amp;rft_id=info:pmid/16585435">&#160;</span></li>
<li id="_note-5"><b><a href="#_ref-5" title="">^</a></b> <cite style="font-style:normal">McEvoy J et al (2006). "Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment". <i>Am J Psychiatry</i> <b>163</b> (4): 600-10. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16585434" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16585434">PMID 16585434</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.atitle=Effectiveness+of+clozapine+versus+olanzapine%2C+quetiapine%2C+and+risperidone+in+patients+with+chronic+schizophrenia+who+did+not+respond+to+prior+atypical+antipsychotic+treatment&amp;rft.title=Am+J+Psychiatry&amp;rft.jtitle=Am+J+Psychiatry&amp;rft.date=2006&amp;rft.volume=163&amp;rft.issue=4&amp;rft.au=McEvoy+J+et+al&amp;rft.pages=600-10&amp;rft_id=info:pmid/16585434">&#160;</span></li>
</ol>
</div>
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12356650&amp;dopt=Abstract" class="external text" title="http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12356650&amp;dopt=Abstract" rel="nofollow">Jones, H. M., &amp; Pilowsky, L. S. (2002)</a> Dopamine and antipsychotic drug action revisited. <i>British Journal of Psychiatry</i>, 181, 271-275.</li>
<li>Jablensky, A. (1992). Schizophrenia: manifestations, incidence and course in different cultures, A World Health Organization ten-country study, Psychological Medicine, 20 1-95.</li>
<li>Prien, R. , Levine, J., &amp; Switalski, R. (1971). Discontinuation of chemotherapy for chronic schizophrenics. Hospital &amp; Community Psychiatry, 22(1), 4-7.</li>
</ul>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/n/t/Antipsychotic.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.mcmanweb.com/article-178.htm" class="external text" title="http://www.mcmanweb.com/article-178.htm" rel="nofollow">Bipolar Meds - The Antipsychotics</a></li>
<li><a href="http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01350.html" class="external text" title="http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01350.html" rel="nofollow">FDA Public Health Advisory</a> - Public Health Advisory for Antipsychotic Drugs used for Treatment of Behavioral Disorders in Elderly Patients</li>
<li><a href="http://www.medicina.ufrj.br/cursos/JBP%202%20COLUNAS%20-%20com%20referencia%20completa%20&amp;%20foto%20-%20AGONISTAS%20PARCIAIS%20NO%20ARMAMENTARIUM.pdf" class="external text" title="http://www.medicina.ufrj.br/cursos/JBP%202%20COLUNAS%20-%20com%20referencia%20completa%20&amp;%20foto%20-%20AGONISTAS%20PARCIAIS%20NO%20ARMAMENTARIUM.pdf" rel="nofollow">FROTA LH. Partial Agonists in the Schizophrenia Armamentarium. Tardive Dysphrenia: The newest challenge to the last generation atypical antipsychotics drugs? J Bras Psiquiatr 2003; Vol 52 Supl 1;14-24. Free full-text in Portuguese with Abstracts in English available here</a></li>
<li><a href="http://www.medicina.ufrj.br/cursos/FROTA%20LIVRO%20I%20&amp;%20II.pdf" class="external text" title="http://www.medicina.ufrj.br/cursos/FROTA%20LIVRO%20I%20&amp;%20II.pdf" rel="nofollow">FROTA LH. Fifty Years of Antipsychotic Drugs in Psychiatry. "Cinqüenta Anos de Medicamentos Antipsicóticos em Psiquiatria." 1st ed; Ebook: CD-Rom/On-Line Portuguese, ISBN 85-903827-1-0, File .pdf (Adobe Acrobat) 6Mb, Informática, Rio de Janeiro, august 2003, 486pp. Free full-text on Portuguese available online here</a></li>
</ul>
<table class="navbox collapsible autocollapse" style="margin: auto; text-align:left">
<tr>
<th colspan="2" style="text-align:center;">
<div style="float:left; text-align:left; width:6em;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap;"><a href="../../../a/n/t/Template%7EAntipsychotics_be5a.html" title="Template:Antipsychotics"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../a/n/t/Template%7EAntipsychotics_be5a.html" class="external text" title="http://en.wikipedia.org../../../a/n/t/Template%7EAntipsychotics_be5a.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
</div>
<strong class="selflink">Antipsychotics</strong> (<a href="../../../a/t/c/ATC_code_N05_53f8.html#N05A_Antipsychotics" title="ATC code N05">N05A</a>)</th>
</tr>
<tr>
<th style=""><a href="../../../p/h/e/Phenothiazine.html" title="Phenothiazine">Phenothiazine</a> <a href="../../../t/y/p/Typical_antipsychotic.html" title="Typical antipsychotic">typical antipsychotics</a></th>
<td style="" colspan="1"><a href="../../../c/h/l/Chlorpromazine.html" title="Chlorpromazine">Chlorpromazine</a>, <a href="../../../f/l/u/Fluphenazine.html" title="Fluphenazine">Fluphenazine</a>, <a href="../../../m/e/s/Mesoridazine.html" title="Mesoridazine">Mesoridazine</a>, <a href="../../../p/e/r/Perphenazine.html" title="Perphenazine">Perphenazine</a>, <a href="../../../p/r/o/Prochlorperazine.html" title="Prochlorperazine">Prochlorperazine</a>, <a href="../../../p/r/o/Promazine.html" title="Promazine">Promazine</a>, <a href="../../../t/h/i/Thioridazine.html" title="Thioridazine">Thioridazine</a>, <a href="../../../t/r/i/Trifluoperazine.html" title="Trifluoperazine">Trifluoperazine</a></td>
</tr>
<tr>
<th style="">Other <a href="../../../t/y/p/Typical_antipsychotic.html" title="Typical antipsychotic">typical antipsychotics</a></th>
<td style="" colspan="1"><a href="../../../c/h/l/Chlorprothixene.html" title="Chlorprothixene">Chlorprothixene</a>, <a href="../../../d/r/o/Droperidol.html" title="Droperidol">Droperidol</a>, <a href="../../../f/l/u/Flupentixol.html" title="Flupentixol">Flupentixol</a>, <a href="../../../b/e/n/Benperidol.html" title="Benperidol">Benperidol</a>,<a href="../../../h/a/l/Haloperidol.html" title="Haloperidol">Haloperidol</a>, <a href="../../../l/o/x/Loxapine.html" title="Loxapine">Loxapine</a>, <a href="../../../m/o/l/Molindone.html" title="Molindone">Molindone</a>, <a href="../../../p/i/m/Pimozide.html" title="Pimozide">Pimozide</a>, <a href="../../../s/u/l/Sulforidazine.html" title="Sulforidazine">Sulforidazine</a>, <a href="../../../t/h/i/Thiothixene.html" title="Thiothixene">Thiothixene</a></td>
</tr>
<tr>
<th style=""><a href="../../../a/t/y/Atypical_antipsychotic.html" title="Atypical antipsychotic">Atypical antipsychotics</a></th>
<td style="" colspan="1"><a href="../../../a/m/i/Amisulpride.html" title="Amisulpride">Amisulpride</a>, <a href="../../../a/r/i/Aripiprazole.html" title="Aripiprazole">Aripiprazole</a>, <a href="../../../c/l/o/Clozapine.html" title="Clozapine">Clozapine</a>, <a href="../../../m/e/l/Melperone.html" title="Melperone">Melperone</a>,<a href="../../../o/l/a/Olanzapine.html" title="Olanzapine">Olanzapine</a>, <a href="../../../q/u/e/Quetiapine.html" title="Quetiapine">Quetiapine</a>, <a href="../../../r/i/s/Risperidone.html" title="Risperidone">Risperidone</a>, <a href="../../../p/a/l/Paliperidone.html" title="Paliperidone">Paliperidone</a>, <a href="../../../s/e/r/Sertindole.html" title="Sertindole">Sertindole</a>, <a href="../../../s/u/l/Sulpiride.html" title="Sulpiride">Sulpiride</a>, <a href="../../../z/i/p/Ziprasidone.html" title="Ziprasidone">Ziprasidone</a>, <a href="../../../z/o/t/Zotepine.html" title="Zotepine">Zotepine</a></td>
</tr>
</table>
<table class="navbox collapsible autocollapse" style="margin: auto; text-align:left">
<tr>
<th colspan="2" style="text-align:center;">
<div style="float:left; text-align:left; width:6em;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap;"><a href="../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" title="Template:Major Drug Groups"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="../../../m/a/j/Template_talk%7EMajor_Drug_Groups_149b.html" title="Template talk:Major Drug Groups"><span title="Discussion about this template">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" class="external text" title="http://en.wikipedia.org../../../m/a/j/Template%7EMajor_Drug_Groups_2544.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
</div>
Major Drug Groups</th>
</tr>
<tr>
<th style=""><a href="../../../b/r/a/Brain.html" title="Brain">Brain</a> and <a href="../../../n/e/r/Nervous_system.html" title="Nervous system">Nervous system</a></th>
<td style="" colspan="1"><a href="../../../a/n/a/Analgesic.html" title="Analgesic">Analgesics</a>, <a href="../../../a/n/e/Anesthesia.html" title="Anesthesia">Anesthetics</a>, <a href="../../../a/n/x/Anxiolytic.html" title="Anxiolytic">Anxiolytics</a>, <a href="../../../a/n/t/Antidepressant.html" title="Antidepressant">Antidepressants</a>, <strong class="selflink">Antipsychotics</strong>, <a href="../../../a/n/t/Anticonvulsant.html" title="Anticonvulsant">Anticonvulsants</a>, <a href="../../../s/t/i/Stimulant.html" title="Stimulant">Nervous system stimulants</a>, <a href="../../../a/n/t/Antiemetic.html" title="Antiemetic">Antiemetics</a>, <a href="../../../p/s/y/Psychedelics%2C_dissociatives_and_deliriants.html" title="Psychedelics, dissociatives and deliriants">Hallucinogens</a>, <a href="../../../m/o/o/Mood_stabilizer.html" title="Mood stabilizer">Mood stabilizers</a></td>
</tr>
<tr>
<th style=""><a href="../../../r/e/s/Respiratory_system.html" title="Respiratory system">Respiratory system</a></th>
<td style="" colspan="1"><a href="../../../b/r/o/Bronchodilator.html" title="Bronchodilator">Bronchodilators</a>, <a href="../../../d/e/c/Decongestant.html" title="Decongestant">Decongestants</a></td>
</tr>
<tr>
<th style=""><a href="../../../h/e/a/Heart.html" title="Heart">Heart</a> and <a href="../../../c/i/r/Circulatory_system.html" title="Circulatory system">Circulation</a></th>
<td style="" colspan="1"><a href="../../../a/c/e/ACE_inhibitor_fd43.html" title="ACE inhibitor">Angiotensin converting enzyme inhibitors</a>, <a href="../../../a/n/t/Antiarrhythmic_agent.html" title="Antiarrhythmic agent">Antiarrhythmics</a>, <a href="../../../a/n/t/Antianginal.html" title="Antianginal">Antianginals</a>, <a href="../../../a/n/t/Antihypertensive.html" title="Antihypertensive">Antihypertensives</a>, <a href="../../../h/y/p/Hypolipidemic_agent.html" title="Hypolipidemic agent">Antihyperlipidemics</a>, <a href="../../../a/n/t/Anticoagulant.html" title="Anticoagulant">Anticoagulants</a>, <a href="../../../a/n/t/Antiplatelet_drug.html" title="Antiplatelet drug">Antiplatelets</a>, <a href="../../../b/e/t/Beta_blocker.html" title="Beta blocker">Beta blockers</a>, <a href="../../../d/i/u/Diuretic.html" title="Diuretic">Diuretics</a>, <a href="../../../t/h/r/Thrombolytic_drug.html" title="Thrombolytic drug">Thrombolytics</a>, <a href="../../../v/a/s/Vasodilator.html" title="Vasodilator">Vasodilators</a></td>
</tr>
<tr>
<th style=""><a href="../../../g/a/s/Gastrointestinal_tract.html" title="Gastrointestinal tract">Gastrointestinal tract</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antacid.html" title="Antacid">Antacids</a>, <a href="../../../a/n/t/Antidiarrhoeal.html" title="Antidiarrhoeal">Antidiarrhoeals</a>, <a href="../../../h/2/-/H2-receptor_antagonist.html" title="H2-receptor antagonist">H2-receptor antagonists</a>, <a href="../../../p/r/o/Proton_pump_inhibitor.html" title="Proton pump inhibitor">Proton pump inhibitors</a>, <a href="../../../l/a/x/Laxative.html" title="Laxative">Laxatives</a></td>
</tr>
<tr>
<th style=""><a href="../../../m/u/s/Muscle.html" title="Muscle">Muscles</a>, <a href="../../../b/o/n/Bone.html" title="Bone">Bones</a>, and <a href="../../../j/o/i/Joint.html" title="Joint">Joints</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Anti-inflammatory.html" title="Anti-inflammatory">Anti-inflammatories</a>, <a href="../../../d/i/s/Disease-modifying_antirheumatic_drug.html" title="Disease-modifying antirheumatic drug">Antirheumatics</a>, <a href="../../../c/o/r/Corticosteroid.html" title="Corticosteroid">Corticosteroids</a>, <a href="../../../m/u/s/Muscle_relaxant.html" title="Muscle relaxant">Muscle relaxants</a></td>
</tr>
<tr>
<th style=""><a href="../../../a/l/l/Allergy.html" title="Allergy">Allergy</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antihistamine.html" title="Antihistamine">Antihistamines</a></td>
</tr>
<tr>
<th style=""><a href="../../../i/n/f/Infection.html" title="Infection">Infections</a> and <a href="../../../i/n/f/Infestation.html" title="Infestation">Infestations</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antibiotic.html" title="Antibiotic">Antibiotics</a>, <a href="../../../a/n/t/Antiviral_drug.html" title="Antiviral drug">Antivirals</a>, <a href="../../../v/a/c/Vaccine.html" title="Vaccine">Vaccines</a>, <a href="../../../a/n/t/Antiprotozoal_agent.html" title="Antiprotozoal agent">Antiprotozoals</a>, <a href="../../../a/n/t/Antifungal_drug.html" title="Antifungal drug">Antifungals</a>, <a href="../../../a/n/t/Anthelmintic.html" title="Anthelmintic">Anthelmintics</a></td>
</tr>
<tr>
<th style=""><a href="../../../e/n/d/Endocrine_system.html" title="Endocrine system">Endocrine system</a></th>
<td style="" colspan="1"><a href="../../../c/o/r/Corticosteroid.html" title="Corticosteroid">Corticosteroids</a>, <a href="../../../a/n/t/Anti-diabetic_drug.html" title="Anti-diabetic drug">Anti-diabetics</a></td>
</tr>
<tr>
<th style=""><a href="../../../m/a/l/Malignant.html" title="Malignant">Malignant</a> and <a href="../../../i/m/m/Immune_system.html" title="Immune system">Immune</a> disease</th>
<td style="" colspan="1"><a href="../../../c/h/e/Chemotherapy.html" title="Chemotherapy">Anticancer agents</a>, <a href="../../../i/m/m/Immunosuppressive_drug.html" title="Immunosuppressive drug">Immunosuppressants</a></td>
</tr>
<tr>
<th style=""><a href="../../../r/e/p/Reproductive_system.html" title="Reproductive system">Reproductive system</a></th>
<td style="" colspan="1"><a href="../../../h/o/r/Hormonal_contraception.html" title="Hormonal contraception">Hormonal contraception</a>, <a href="../../../f/e/r/Fertility_medication.html" title="Fertility medication">Fertility agents</a>, <a href="../../../s/e/l/Selective_estrogen_receptor_modulator.html" title="Selective estrogen receptor modulator">Selective estrogen receptor modulators</a></td>
</tr>
<tr>
<th style=""><a href="../../../s/k/i/Skin.html" title="Skin">Skin</a></th>
<td style="" colspan="1"><a href="../../../a/n/t/Antipruritic.html" title="Antipruritic">Antipruritics</a></td>
</tr>
</table>

<!-- 
Pre-expand include size: 57184 bytes
Post-expand include size: 29924 bytes
Template argument size: 16301 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/n/t/Antipsychotic.html">http://en.wikipedia.org../../../a/n/t/Antipsychotic.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_with_unsourced_statements_since_February_2007_f7dc.html" title="Category:Articles with unsourced statements since February 2007">Articles with unsourced statements since February 2007</a></span> | <span dir='ltr'><a href="../../../a/l/l/Category%7EAll_articles_with_unsourced_statements_2f67.html" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_which_may_contain_original_research_471f.html" title="Category:Articles which may contain original research">Articles which may contain original research</a></span> | <span dir='ltr'><a href="../../../w/i/k/Category%7EWikipedia_articles_needing_factual_verification_4aa5.html" title="Category:Wikipedia articles needing factual verification">Wikipedia articles needing factual verification</a></span> | <span dir='ltr'><a href="../../../a/c/c/Category%7EAccuracy_disputes_ce25.html" title="Category:Accuracy disputes">Accuracy disputes</a></span> | <span dir='ltr'><a href="../../../a/r/t/Category%7EArticles_with_unsourced_statements_since_April_2007_ad01.html" title="Category:Articles with unsourced statements since April 2007">Articles with unsourced statements since April 2007</a></span> | <span dir='ltr'><a href="../../../a/n/t/Category%7EAntipsychotics_9960.html" title="Category:Antipsychotics">Antipsychotics</a></span> | <span dir='ltr'><a href="../../../p/s/y/Category%7EPsychiatry_af68.html" title="Category:Psychiatry">Psychiatry</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/n/t/Antipsychotic.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/n/t/Talk%7EAntipsychotic_3bb2.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Antipsychotic">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../af/a/n/t/Antipsigotikum.html">Afrikaans</a>
	      </li>
	      	      <li>
	      <a href="../../../../cs/a/n/t/Antipsychotika.html">Česky</a>
	      </li>
	      	      <li>
	      <a href="../../../../de/n/e/u/Neuroleptikum.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../es/n/e/u/Neurol%C3%A9ptico.html">Español</a>
	      </li>
	      	      <li>
	      <a href="../../../../fr/n/e/u/Neuroleptique.html">Français</a>
	      </li>
	      	      <li>
	      <a href="../../../../io/n/e/u/Neuroleptiko.html">Ido</a>
	      </li>
	      	      <li>
	      <a href="../../../../hu/n/e/u/Neuroleptikum.html">Magyar</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/a/n/t/Antipsychoticum.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../ja/%E6%8A%97/%E7%B2%BE/%E7%A5%9E/%E6%8A%97%E7%B2%BE%E7%A5%9E%E7%97%85%E8%96%AC.html">日本語</a>
	      </li>
	      	      <li>
	      <a href="../../../../no/a/n/t/Antipsykotika.html">‪Norsk (bokmål)‬</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/l/e/k/Leki_przeciwpsychotyczne.html">Polski</a>
	      </li>
	      	      <li>
	      <a href="../../../../pt/a/n/t/Antipsic%C3%B3tico.html">Português</a>
	      </li>
	      	      <li>
	      <a href="../../../../ru/%D0%B0/%D0%BD/%D1%82/%D0%90%D0%BD%D1%82%D0%B8%D0%BF%D1%81%D0%B8%D1%85%D0%BE%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D0%BF%D1%80%D0%B5%D0%BF%D0%B0%D1%80%D0%B0%D1%82%D1%8B.html">Русский</a>
	      </li>
	      	      <li>
	      <a href="../../../../sk/n/e/u/Neuroleptikum.html">Slovenčina</a>
	      </li>
	      	      <li>
	      <a href="../../../../fi/a/n/t/Antipsykoottinen_l%C3%A4%C3%A4ke.html">Suomi</a>
	      </li>
	      	      <li>
	      <a href="../../../../sv/n/e/u/Neuroleptika.html">Svenska</a>
	      </li>
	      	      <li>
	      <a href="../../../../zh/%E6%8A%97/%E7%B2%BE/%E7%A5%9E/%E6%8A%97%E7%B2%BE%E7%A5%9E%E7%97%85%E8%8D%AF.html">中文</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 02:13, 5 April 2007 by Anonymous user(s) of Wikipedia. Based on work by Wikipedia user(s) <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../m/a/s/User%7EMastCell_1b0e.html" title="User:MastCell">MastCell</a>, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, <a href="../../../p/w/j/User%7EPwjb_b512.html" title="User:Pwjb">Pwjb</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../s/h/a/User%7EShandris_1379.html" title="User:Shandris">Shandris</a>, <a href="../../../j/o/e/User%7EJoel2016_be48.html" title="User:Joel2016">Joel2016</a>, <a href="../../../c/o/e/User%7ECoemgenus_b232.html" title="User:Coemgenus">Coemgenus</a>, <a href="../../../d/e/l/User%7EDeli_nk_ed07.html" title="User:Deli nk">Deli nk</a>, <a href="../../../d/o/c/User%7EDoczilla_1c36.html" title="User:Doczilla">Doczilla</a>, <a href="../../../k/a/t/User%7EKathryn_NicDh%C3%A0na_9cdf.html" title="User:Kathryn NicDhàna">Kathryn NicDhàna</a>, <a href="../../../m/e/t/User%7EMetsFan76_ea64.html" title="User:MetsFan76">MetsFan76</a>, <a href="../../../b/e/n/User%7EBenjaminevans82_7c6f.html" title="User:Benjaminevans82">Benjaminevans82</a>, <a href="../../../c/m/d/User%7ECmdrObot_0605.html" title="User:CmdrObot">CmdrObot</a>, Postcrypto, <a href="../../../t/h/i/User%7EThijs%21bot_bdf4.html" title="User:Thijs!bot">Thijs!bot</a>, Jco7, <a href="../../../v/e/i/User%7EVeinor_0082.html" title="User:Veinor">Veinor</a>, Agjchs, <a href="../../../s/t/b/User%7ESTBotD_8c4f.html" title="User:STBotD">STBotD</a>, Drugdelivery, <a href="../../../k/r/i/User%7EKriegman_fe46.html" title="User:Kriegman">Kriegman</a>, <a href="../../../m/i/c/User%7EMichael_Daly_3133.html" title="User:Michael Daly">Michael Daly</a>, Ajg23, <a href="../../../d/o/r/User%7EDorganBot_b7c4.html" title="User:DorganBot">DorganBot</a>, Tins128, <a href="../../../r/u/t/User%7ERutigor_9d82.html" title="User:Rutigor">Rutigor</a>, <a href="../../../m/a/r/User%7EMarcus_wilby73_b8e7.html" title="User:Marcus wilby73">Marcus wilby73</a>, <a href="../../../u/r/o/User%7EUrod_afcd.html" title="User:Urod">Urod</a>, <a href="../../../p/a/l/User%7EPalica_fbf7.html" title="User:Palica">Palica</a>, <a href="../../../n/e/u/User%7ENeur0X_e171.html" title="User:Neur0X">Neur0X</a>, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, <a href="../../../e/p/o/User%7EEpolk_d8a6.html" title="User:Epolk">Epolk</a>, <a href="../../../w/e/g/User%7EWeggeBot_7120.html" title="User:WeggeBot">WeggeBot</a>, <a href="../../../a/n/i/User%7EAnilverma_9a19.html" title="User:Anilverma">Anilverma</a>, <a href="../../../d/e/z/User%7EDezidor_bb18.html" title="User:Dezidor">Dezidor</a>, <a href="../../../s/a/n/User%7ESandyGeorgia_1007.html" title="User:SandyGeorgia">SandyGeorgia</a>, <a href="../../../a/v/a/User%7EAvalyn_8a13.html" title="User:Avalyn">Avalyn</a>, LFROTA, <a href="../../../a/h/s/User%7EAhseaton_bf34.html" title="User:Ahseaton">Ahseaton</a>, <a href="../../../s/o/a/User%7ESoakologist_50a6.html" title="User:Soakologist">Soakologist</a>, <a href="../../../r/h/y/User%7ERhys_16a8.html" title="User:Rhys">Rhys</a>, <a href="../../../v/a/u/User%7EVaughan_120e.html" title="User:Vaughan">Vaughan</a>, <a href="../../../r/i/c/User%7ERich_Farmbrough_7642.html" title="User:Rich Farmbrough">Rich Farmbrough</a>, <a href="../../../m/o/o/User%7EMoop_stick_83ef.html" title="User:Moop stick">Moop stick</a>, DrPak, <a href="../../../u/t/h/User%7EUthbrian_6843.html" title="User:Uthbrian">Uthbrian</a>, <a href="../../../c/a/c/User%7ECacycle_6f2f.html" title="User:Cacycle">Cacycle</a>, <a href="../../../s/k/a/User%7ESkagedal_c3c6.html" title="User:Skagedal">Skagedal</a>, <a href="../../../c/e/y/User%7ECeyockey_fb55.html" title="User:Ceyockey">Ceyockey</a>, <a href="../../../j/f/u/User%7EJfurr1981_6930.html" title="User:Jfurr1981">Jfurr1981</a>, <a href="../../../a/z/a/User%7EAzadMashari_b33d.html" title="User:AzadMashari">AzadMashari</a>, <a href="../../../o/c/t/User%7EOctavio_L_a603.html" title="User:Octavio L">Octavio L</a>, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, <a href="../../../f/t/w/User%7EFtWashGuy_e4be.html" title="User:FtWashGuy">FtWashGuy</a>, <a href="../../../c/2E/l/User%7EC.L%C3%B6ser_43ab.html" title="User:C.Löser">C.Löser</a>, <a href="../../../r/m/k/User%7ERmky87_07f5.html" title="User:Rmky87">Rmky87</a>, <a href="../../../s/a/m/User%7ESam_Hocevar_dccf.html" title="User:Sam Hocevar">Sam Hocevar</a>, <a href="../../../t/a/n/User%7ETangParadise_3ce6.html" title="User:TangParadise">TangParadise</a>, <a href="../../../s/a/l/User%7ESalvadorjo_220f.html" title="User:Salvadorjo">Salvadorjo</a>, <a href="../../../p/a/c/User%7EPacula_c10e.html" title="User:Pacula">Pacula</a>, <a href="../../../d/a/v/User%7EDaveb_b30a.html" title="User:Daveb">Daveb</a>, <a href="../../../r/d/s/User%7ERdsmith4_389f.html" title="User:Rdsmith4">Rdsmith4</a>, <a href="../../../e/r/a/User%7EEras-mus_f9f9.html" title="User:Eras-mus">Eras-mus</a>, <a href="../../../b/r/i/User%7EBrian0918_0727.html" title="User:Brian0918">Brian0918</a>, <a href="../../../a/x/l/User%7EAxl_2118.html" title="User:Axl">Axl</a>, <a href="../../../e/l/b/User%7EElBenevolente_e171.html" title="User:ElBenevolente">ElBenevolente</a>, <a href="../../../t/h/i/User%7EThickslab_c7ef.html" title="User:Thickslab">Thickslab</a>, <a href="../../../l/y/s/User%7ELysdexia_bda0.html" title="User:Lysdexia">Lysdexia</a>, <a href="../../../m/i/n/User%7EMintleaf_bb08.html" title="User:Mintleaf">Mintleaf</a>, <a href="../../../e/e/q/User%7EEequor_b13d.html" title="User:Eequor">Eequor</a>, <a href="../../../w/h/i/User%7EWhig_4cfc.html" title="User:Whig">Whig</a>, <a href="../../../j/i/m/User%7EJimClark_670d.html" title="User:JimClark">JimClark</a>, <a href="../../../l/i/f/User%7ELiftarn_fddd.html" title="User:Liftarn">Liftarn</a>, <a href="../../../a/n/g/User%7EAngela_56ea.html" title="User:Angela">Angela</a>, <a href="../../../z/i/g/User%7EZigger_b33b.html" title="User:Zigger">Zigger</a>, <a href="../../../r/t/c/User%7ERTC_4798.html" title="User:RTC">RTC</a>, <a href="../../../m/a/x/User%7EMaximus_Rex_f7db.html" title="User:Maximus Rex">Maximus Rex</a>, <a href="../../../m/a/v/User%7EMaveric149_24ee.html" title="User:Maveric149">Maveric149</a>, <a href="../../../s/a/l/User%7ESalsa_Shark_0519.html" title="User:Salsa Shark">Salsa Shark</a>, <a href="../../../p/f/o/User%7EPfortuny_f17f.html" title="User:Pfortuny">Pfortuny</a>, <a href="../../../n/a/d/User%7ENaddy_8480.html" title="User:Naddy">Naddy</a>, <a href="../../../r/o/a/User%7ERoadrunner_b57c.html" title="User:Roadrunner">Roadrunner</a>, <a href="../../../m/y/r/User%7EMyRedDice_bcb5.html" title="User:MyRedDice">MyRedDice</a>, <a href="../../../s/u/s/User%7ESusan_Mason_3ada.html" title="User:Susan Mason">Susan Mason</a>, <a href="../../../t/z/u/User%7ETzuhou_d267.html" title="User:Tzuhou">Tzuhou</a>, <a href="../../../h/e/p/User%7EHephaestos_c32a.html" title="User:Hephaestos">Hephaestos</a>, <a href="../../../k/o/y/User%7EKoyaanis_Qatsi_7ab5.html" title="User:Koyaanis Qatsi">Koyaanis Qatsi</a>, <a href="../../../r/o/s/User%7ERoseParks_d19f.html" title="User:RoseParks">RoseParks</a> and <a href="../../../t/w/o/User%7ETwoOneTwo_b3fe.html" title="User:TwoOneTwo">TwoOneTwo</a>.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
